Usage: Ambien (zolpidem tartrate) is indicated for the short-term treatment of insomnia in adults who have difficulty falling asleep. Clinical studies support its use for up to 35 days.
Usage: Ambien CR (zolpidem tartrate extended-release) is indicated for short-term treatment of insomnia with difficulties in sleep onset and/or sleep maintenance in adults and elderly patients.
Usage: Elitek manages elevated plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, or solid tumor malignancies receiving anticancer therapy expected to cause tumor lysis. Indicated for a single course of treatment only.